Severe Liver and Skin Toxicity After Radiation and Vemurafenib in Metastatic Melanoma-Reference-Cited by-同舟云学术

Severe Liver and Skin Toxicity After Radiation and Vemurafenib in Metastatic Melanoma

Published:2013-06-10 Issue:17 Volume:31 Page:e283-e287
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Anker Christopher J.¹,Ribas Antoni²,Grossmann Allie H.³,Chen Xinjian³,Narra Krishna K.³,Akerley Wallace⁴,Andtbacka Robert H. I.⁴,Noyes Robert Dirk⁵,Shrieve Dennis C.¹,Grossmann Kenneth F.⁴

Affiliation:

1. Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT

2. Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA

3. University of Utah, Salt Lake City, UT

4. Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

5. Intermountain Healthcare, Salt Lake City, UT

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2012.44.7755

Reference17 articles.

1. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

2. Broad-Shouldered Survival Curves of a Human Melanoma Xenograft Implications for radiation therapy in the absence and presence of misonidazole

3. A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma

4. Fraction size in external beam radiation therapy in the treatment of melanoma

5. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic body radiation therapy for liver metastases in oligometastatic disease;Cancer/Radiothérapie;2024-02

2. Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma;Biomedicines;2023-01-29

3. 皮膚がん診療における放射線治療の役割;Skin Cancer;2023

4. Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted Therapies;Advances in Radiation Oncology;2022-11

5. Malignant Melanoma;Holland‐Frei Cancer Medicine;2022-10-21